Literature DB >> 25212440

Focus article: report of the NIH Task Force on Research Standards for Chronic Low Back Pain.

Richard A Deyo1, Samuel F Dworkin, Dagmar Amtmann, Gunnar Andersson, David Borenstein, Eugene Carragee, John Carrino, Roger Chou, Karon Cook, Anthony DeLitto, Christine Goertz, Partap Khalsa, John Loeser, Sean Mackey, James Panagis, James Rainville, Tor Tosteson, Dennis Turk, Michael Von Korff, Debra K Weiner.   

Abstract

UNLABELLED: Despite rapidly increasing intervention, functional disability due to chronic low back pain (cLBP) has increased in recent decades. We often cannot identify mechanisms to explain the major negative impact cLBP has on patients' lives. Such cLBP is often termed non-specific and may be due to multiple biologic and behavioral etiologies. Researchers use varied inclusion criteria, definitions, baseline assessments, and outcome measures, which impede comparisons and consensus. Therefore, NIH Pain Consortium charged a Research Task Force (RTF) to draft standards for research on cLBP. The resulting multidisciplinary panel recommended using 2 questions to define cLBP; classifying cLBP by its impact (defined by pain intensity, pain interference, and physical function); use of a minimum dataset to describe research participants (drawing heavily on the PROMIS methodology); reporting "responder analyses" in addition to mean outcome scores; and suggestions for future research and dissemination. The Pain Consortium has approved the recommendations, which investigators should incorporate into NIH grant proposals. The RTF believes that these recommendations will advance the field, help to resolve controversies, and facilitate future research addressing the genomic, neurologic, and other mechanistic substrates of chronic low back pain. We expect that the RTF recommendations will become a dynamic document and undergo continual improvement. PERSPECTIVE: A task force was convened by the NIH Pain Consortium with the goal of developing research standards for chronic low back pain. The results included recommendations for definitions, a minimum dataset, reporting outcomes, and future research. Greater consistency in reporting should facilitate comparisons among studies and the development of phenotypes.

Entities:  

Mesh:

Year:  2014        PMID: 25212440     DOI: 10.1007/s00586-014-3540-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  112 in total

Review 1.  Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.

Authors:  Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

2.  A prognostic approach to defining chronic pain: application to knee pain in older adults.

Authors:  Elaine Thomas; Kate M Dunn; Christian Mallen; George Peat
Journal:  Pain       Date:  2008-06-25       Impact factor: 6.961

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Relationship between categorization with the STarT Back Screening Tool and prognosis for people receiving physical therapy for low back pain.

Authors:  Julie M Fritz; Jason M Beneciuk; Steven Z George
Journal:  Phys Ther       Date:  2011-03-30

5.  Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments.

Authors:  Daniel J Buysse; Lan Yu; Douglas E Moul; Anne Germain; Angela Stover; Nathan E Dodds; Kelly L Johnston; Melissa A Shablesky-Cade; Paul A Pilkonis
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

Review 6.  Interpreting patient-reported outcome results: US FDA guidance and emerging methods.

Authors:  Lori D McLeod; Cheryl D Coon; Susan A Martin; Sheri E Fehnel; Ron D Hays
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-04       Impact factor: 2.217

7.  Expenditures and health status among adults with back and neck problems.

Authors:  Brook I Martin; Richard A Deyo; Sohail K Mirza; Judith A Turner; Bryan A Comstock; William Hollingworth; Sean D Sullivan
Journal:  JAMA       Date:  2008-02-13       Impact factor: 56.272

8.  Determining mild, moderate, and severe pain equivalency across pain-intensity tools in nursing home residents.

Authors:  Katherine R Jones; Carol P Vojir; Evelyn Hutt; Regina Fink
Journal:  J Rehabil Res Dev       Date:  2007

9.  Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference.

Authors:  Erin E Krebs; Karl A Lorenz; Matthew J Bair; Teresa M Damush; Jingwei Wu; Jason M Sutherland; Steven M Asch; Kurt Kroenke
Journal:  J Gen Intern Med       Date:  2009-05-06       Impact factor: 5.128

10.  Cutpoints for mild, moderate and severe pain in patients with osteoarthritis of the hip or knee ready for joint replacement surgery.

Authors:  Heidi Kapstad; Berit R Hanestad; Norvald Langeland; Tone Rustøen; Knut Stavem
Journal:  BMC Musculoskelet Disord       Date:  2008-04-21       Impact factor: 2.362

View more
  27 in total

1.  The Canadian minimum dataset for chronic low back pain research: a cross-cultural adaptation of the National Institutes of Health Task Force Research Standards.

Authors:  Anaïs Lacasse; Jean-Sébastien Roy; Alexandre J Parent; Nioushah Noushi; Chúk Odenigbo; Gabrielle Pagé; Nicolas Beaudet; Manon Choinière; Laura S Stone; Mark A Ware
Journal:  CMAJ Open       Date:  2017-03-10

Review 2.  The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the "medical" articles in the European Spine Journal, 2014.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2014-12-06       Impact factor: 3.134

Review 3.  The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the "surgical research" articles in the European Spine Journal 2014.

Authors:  Robert C Mulholland
Journal:  Eur Spine J       Date:  2015-01-03       Impact factor: 3.134

4.  The Core Outcome Measures Index (COMI) is a responsive instrument for assessing the outcome of treatment for adult spinal deformity.

Authors:  A F Mannion; A Vila-Casademunt; M Domingo-Sàbat; S Wunderlin; F Pellisé; J Bago; E Acaroglu; A Alanay; F S Pérez-Grueso; I Obeid; F S Kleinstück
Journal:  Eur Spine J       Date:  2015-10-30       Impact factor: 3.134

5.  Low back pain: in search of goddess Panacea.

Authors:  R Gunzburg
Journal:  Eur Spine J       Date:  2014-09-25       Impact factor: 3.134

6.  Virtual immersive gaming to optimize recovery (VIGOR) in low back pain: A phase II randomized controlled trial.

Authors:  Christopher R France; James S Thomas
Journal:  Contemp Clin Trials       Date:  2018-05-03       Impact factor: 2.226

Review 7.  Development of a standard set of outcome measures for non-specific low back pain in Dutch primary care physiotherapy practices: a Delphi study.

Authors:  A C Verburg; S A van Dulmen; H Kiers; M W G Nijhuis-van der Sanden; P J van der Wees
Journal:  Eur Spine J       Date:  2019-04-19       Impact factor: 3.134

8.  Spinopelvic parameter changes and low back pain improvement due to femoral neck anteversion in patients with severe unilateral primary hip osteoarthritis undergoing total hip replacement.

Authors:  Andrea Piazzolla; Giuseppe Solarino; Davide Bizzoca; Viola Montemurro; Pedro Berjano; Claudio Lamartina; Carlotta Martini; Biagio Moretti
Journal:  Eur Spine J       Date:  2017-03-16       Impact factor: 3.134

9.  Low Back Pain Prevalence and Related Workplace Psychosocial Risk Factors: A Study Using Data From the 2010 National Health Interview Survey.

Authors:  Haiou Yang; Scott Haldeman; Ming-Lun Lu; Dean Baker
Journal:  J Manipulative Physiol Ther       Date:  2016-08-25       Impact factor: 1.437

Review 10.  Surgical versus non-surgical treatment for lumbar spinal stenosis.

Authors:  Fabio Zaina; Christy Tomkins-Lane; Eugene Carragee; Stefano Negrini
Journal:  Cochrane Database Syst Rev       Date:  2016-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.